Synthesis, Characterization, and Preliminary Structure Activity Evaluation of Mannich Base Derivatives of 2-Mercaptobenzimidazole

Authors:
  • Hafiz Aamir Ali Kharl , Narcotics Forensic Laboratory, Anti-Narcotics Force, Ministry of Interior & Narcotics Control Islamabad, Pakistan.
  • Maryam Mumshad Raja , Faculty of Pharmacy, Ibadat International University, Islamabad, Pakistan.
  • Rabbia Aslam , Faculty of Pharmacy, Ibadat International University, Islamabad, Pakistan.
  • Sadais Ahmed , Department of Pharmacy, Mirpur University of Science & Technology, Mirpur Azad Jammu & Kahmir.
  • Waqar Ahmad , Faculty of Pharmacy, Capital University of Science & Technology, Islamabad, Pakistan.
  • Sadia Awan , Department of Public Health, Health Services Academy, Islamabad, Pakistan.
  • Uzma Owais , Faculty of Pharmacy, Ibadat International University, Islamabad, Pakistan.
  • Muhammad Mehmood Moin Ul Haq , Faculty of Pharmacy, Capital University of Science & Technology, Islamabad, Pakistan.
  • Sobia Fazal , Faculty of Pharmacy, Capital University of Science & Technology, Islamabad, Pakistan.
  • Muhammad Nouman Arif , Department of Pharmacy, Iqra University H-9 Campus, Islamabad, Pakistan.
  • Fariha Javaid , School of Biochemistry & Biotechnology, University of the Punjab, Lahore, Pakistan

Article Information:

Published:February 8, 2026
Article Type:Original Research
Pages:1099 - 1108
Received:November 29, 2025
Accepted:January 20, 2026

Abstract:

The unceasing development of resistance to drugs requires the discovery of new bioactive compounds and the enhancement of pharmacological properties in small molecules. In this research, a series of twelve derivatives of 2-Mercaptobenzimidazole (AK1-AK12) were successfully prepared from formaldehyde, benzaldehyde, and 4-chlorobenzaldehyde as linkers, as well as from various secondary amines such as diethanolamine, 4-hydroxydiphenylamine, and a few fragments of drugs. The resulted compounds were prepared under mild acidic conditions in ethanol/methanol solvents, and good to excellent yields (68-92%) of the desired compounds were achieved. The prepared compounds were identified by thin layer chromatography, melting point measurements, and FT-IR and 1HNMR analyses, demonstrating the success of aminomethylation and the creation of new C-N/C-S bonds. The initial physicochemical studies of the prepared compounds showed that aromatic and medicinal Mannich base derivatives possessed relatively enhanced activities. Electron-withdrawing groups played a positive role in such effects. In principle, despite the challenges and complexity of pharmacological studies, the results of such studies indicate the potential of new Mannich base derivatives of 2-mercaptobenzimidazole as templates in further pharmacological optimization.

Keywords:

Mannich base 2-Mercaptobenzimidazole Secondary amines Linkers Structure activity relationship.

Article :

INTRODUCTION:

With an increase in drug resistance, it is the need of time to discover new pathways to synthesize new drugs having potent therapeutic activity but limited side effects. An increase in scientific knowledge gives an efficient manner to synthesize libraries containing hundred to thousand compounds but breakthrough discoveries relevant to disease continued to be slow and debatable (Galloway et al., 2010).

 

For this purpose small molecules having any sort of biological activities but not having any specific target like protein are synthesized and derivatize to find out the biological pathway in cells or organisms (Ali et al., 2025. One of other objective is to synthesize small molecules having the ability to regulate any biological pathway so that helps to identify therapeutic protein targets ((Abbasi et al., 2021, Welsch et al., 2010). Nowadays new strategy for drug discovery is the use of advantageous scaffolds having any potent bioactivity and can serve as ligands for a diverse list of receptors (Kuehnert et al., 2001).

 

2-Mercaptobenzimidazole is derived from benzimidazole having thiol group in the 2- position. Its synonyms are benzimidazole-2-thion, o-phenylen thiourea with a molecular formula of C7H6N2S (Husain et al., 2011). It can react easily to give derivatives having substitution at Sulphur or Nitrogen atoms (Ahamed et al., 2013). It possesses C=S and C-S-H groups, hence it can occur in the dimer (Fahmy et al., 1986) and show the property of tautomerism, thiol, and thione form (Reddy et al., 2008).

 

2-Mercaptobenzimidazole derivatives have been synthesized and reported to exhibit a variety of biological activities including analgesic (Anandarajagopal et al., 2010), antiallergy H1 receptor blocker (Mor et al., 2004), neutropic (Bakhareva et al., 1996), antimicrobial (Mauro et al., 2007). Besides medicinal importance, this Pharmacophore possesses non-biological activities including plant growth regulators (Rebstock et al., 1955), anti-oxidant for plastics and rubber (Norford et al., 1993), insecticidal (Saxena et al., 1982).

 

Mannich Reaction History

Mannich reaction is one of the basic and significant reaction, it has a large diversity of functional groups, hence it has grown in modern chemistry (Mannich and Krösche, 1912). Amino alkylation is done easily during Mannich reaction which allows the synthesis of derivatives (Luo et al., 2009). The classical Mannich reactions have limitations such as competitive aldol condensation and regioselectivity but nowadays these limitations are overcome by using optimal catalyst and reaction conditions along with utilizing new functional groups, imines and enolates (Yang et al., 2011). Mannich reaction is a condensation reaction between diverse substrates having at least one active hydrogen atom, an aldehyde component (generally R1-CHO) and an amine (primary or secondary) reagent which results to a class of compounds generally known as Mannich bases. In Mannich reaction nucleophilic substitution reaction takes place via active hydrogen atom compound allowed to react with aldehyde or amine (primary or secondary), the final product is amine compound known as Mannich base having N, S linked to the R substrate through methylene bridge (Tramontini and Angiolini, 1994).

 

Mannich reaction mechanism

Mannich reaction is a condensation reaction including substrate (nucleus), amine (primary or secondary) linker (aldehyde). Mannich reaction occurs in two steps.

1)                The reaction between amine and linker to form methyleneimmonium salt

2)                Methyleneimmonium salt attacks the substrate to form Mannich base (Tramontini and Angiolini, 1994).

 

Reactants Of Mannich Reaction

Mannich reaction is a condensation of a compound containing an active H atom, despite that is attached to C, N, S or other atoms. Only reaction conditions and reagents differ in each case. The functional group is a vital basic component of Pharmacophore so that aminomethylation can occur dynamically (Ried and Stahlhofen, 1957). Substrates having nucleophilic properties are preferred, -XH compounds having –X is equivalent to -C, -S or any other heteroatom, -NH substrates might be amides, amines or heterocycles. Mannich products of alcohols are mostly stable (Tramontini, 1973). Like substrates amine or drug also contains one active H atom to proceed with the reaction. Secondary amines are preferred as they give mono substituted Mannich bases whereas primary amines will give double Mannich bases which are not as suitable as the prior one. Hydroxylamine derivatives, ammonia, and hydrazine are used as well as drugs containing suitable functional groups were also used (Tramontini and Angiolini, 1990). Formalin 37% is most commonly used as a linker, it is employed to make methylene bridge between substrates and amine groups (Tramontini and Angiolini, 1990). Moreover, many other aldehydes including Benzaldehyde, 4-chlorobenzaldehyde, 4- bromobenzaldehyde and so on are used as linker (Desai and Desai, 2006).

MATERIALS & METHODS:

All the chemicals, which were used, are manufactured by Merck, Sigma Aldrich, Daejung and utilized in the synthesis of Mannich based derivatives of 2-Mercaptobenzimidazole.

 

Materials

Table 1: Description of substrate, linkers, secondary amines and solvents

Substrate

Linker

Secondary Amine/Drug

Solvent/

Catalyst

 

 

 

2-Mercaptobezimidazole

Formalin

4-Hydroxydiphenyl amine

Methanol

4-Chlorobenzaldehyde

Diethanolamine

Ethanol

Benzaldehyde

Tizanidine HCl

Acetone

 

Ceftazidime. 5H2O

Ethyl acetate

 

Cefotaxime Na

Conc. HCl

 

Methods

Optimization and general synthesis mechanism

For the process of optimization, we use different solvents (Ethanol, Methanol), to obtain the maximum yield of the product. Different TLC systems were employed for checking reaction progress n-Hexane: Ethyl Acetate (3:1), n-Hexane: Ethyl Acetate (1:1), Chloroform: Ethanol (9:1). Among these (3:1) system and Ethanol as a solvent gives maximum yield. A mixture of equimolar 2-Mercaptobenzimidazole (0.01mol) and linkers Formalin, Benzaldehyde, 4-Chlorobenzaldehyde (0.01mol) was taken in a round bottom flask containing Methanol (30ml). Reflux this reaction mixture for approximately 1 hour along with gentle stirring. After stirring secondary amine/drug (0.01mol) was added and refluxed for 8-10 hours. TLC was employed to check the progress of the reaction, after reaction completion, the filtrate was cooled and dried, if needed the recrystallized product is recovered by using an organic solvent (Ethanol/n- Hexane) (Gupta et al., 2015).

 

Scheme 1: Scheme of synthesis of Mannich based derivatives of 2-Mercaptobenzimidazole

 

Table 2: Description of R1, R2 and R3 substitution

 

Compounds

 

R1

R2

R3

AK1

Formalin

Phenol

Benzene

AK2

4-Chlorobenzaldehyde

Phenol

Benzene

AK3

Benzaldehyde

Phenol

Benzene

AK4

Benzaldehyde

Hydoxyethyl

Hydoxyethyl

AK5

Formalin

Hydoxyethyl

Hydoxyethyl

AK6

4-Chlorobenzaldehyde

Hydoxyethyl

Hydoxyethyl

 

 

Drugs

AK7

4-Chlorobenzaldehyde

Tizanidine

AK8

Formalin

Tizanidine

AK9

Benzaldehyde

Tizanidine

AK10

4-Chlorobenzaldehyde

Ceftazidime

AK11

Benzaldehyde

Cefotaxime

AK12

4-Chlorobenzaldehyde

Cefotaxime

 

Characterization

The newly synthesized compound did not require any further type of purification and they were recrystallized out by using different solvents (Ethanol). TLC made by Merck TLC Silica gel 60 F254 performed to verify the purity during synthesis. TLC is the most economical way to identify the ongoing synthesis, by this technique numbers of components in a mixture are determined and the extent of reaction can be determined. Different spots will give information about the formation of the product, unreacted components, and impurity. The spots were visualized by using an ultraviolet lamp having a wavelength between 254nm to 366nm. The mobile phase used consist of n-hexane, ethyl acetate (3:1). Change in melting point indicates the synthesis of the new compound, Gallen Kamp apparatus is used to determine the melting point of newly synthesized compounds. The solubility of any compound gives characteristic properties, the newly synthesized compounds show different solubility as compared to the parent molecule. FTIR and 1HNMR spectroscopy is employed to determine the structure of newly synthesized compounds.

RESULTS:

Synthesis of compounds was carried out by using a scheme mentioned in section 2.2. The purity and reaction proceeding was checked by the help of TLC. TLC confirms that reaction yields a pure compound having only one spot. The melting point was determined by using Gallen Kamp apparatus. Structures of the newly synthesized compounds were verified by FTIR and 1HNMR spectroscopy. Finally, compounds were evaluated for antioxidant activity, antibacterial, antifungal, Brine shrimp lethality assay for confirmation of biological activities.

 

Physico-chemical Properties of Synthesized Compounds 

All compounds were obtained in fine crystalline powder by recrystallization technique. Detailed physical characteristics are given in the table. Following table 3.1 shows physico-chemical properties of synthesized compounds.

 

Table 3. Physico-chemical properties of synthesized compounds (AK1-AK12)

Code

Description

Washing

Physical State

Melting Point

Molecular Weight

%

Yield

AK1

0.01M of nucleus 2-MB+4HDPA+HCHO dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Greenish Black Powder

184

347g/mol

91%

AK2

0.01M of nucleus 2-MB+4HDPA+4-CBA

dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Green Powder

171

457g/mol

82%

 

AK3

0.01M of nucleus 2-MB+4HDPA+BEA dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Green Powder

164

423g/mol

68.3%

 

AK4

0.01M of nucleus 2-MB+DEA+BEA dissolved in 30ml Methanol, few drops of

HCl (3:1 n-Hexane: EA)

n-Hexane

Brown Sticky

Powder

147

343g/mol

72.5%

 

AK5

0.01M of nucleus 2-MB+DEA+HCHO dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Yellow Powder

149

267g/mol

92%

 

AK6

0.01M of nucleus 2-MB+DEA+4-CBA dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane Ethanol soluble on heating

Yellow Luster Powder

143

377g/mol

79.4%

 

AK7

0.01M of nucleus 2-MB+TZN+4-CBA dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane Ethanol soluble on heating

Yellow Powder

205

525g/mol

91.4%

 

AK8

0.01M of nucleus 2-MB+TZN+HCHO dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Yellow Powder

198

415g/mol

89.3%

 

AK9

0.01M of nucleus 2-MB+TZN+BEA dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Dull Yellow Powder

212

491g/mol

85.7%

 

AK10

0.01M of nucleus 2-MB+CFT+4-CBA dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Orange Powder

201

820g/mol

89.2%

 

AK11

0.01M  of    nucleus  2-MB+CFX+BEA

dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Orange Powder

211

691g/mol

74%

AK12

0.01M of nucleus 2-MB+CFT+4-CBA dissolved in 30ml Methanol, few drops of HCl (3:1 n-Hexane: EA)

n-Hexane

Yellow Powder

207

725g/mol

81%

 

FTIR Spectral Data of Synthesized Compounds

FTIR is a tool to confirm different functional groups, expected stretches of a secondary amine, hydroxyl, imidazole, was observed at expected wave number. Values are enlisted in the table below. Following table 3.2 shows FTIR of synthesized compounds.

 

Table 4. FTIR Spectral Data of synthesized compounds (AK1-AK12)

Compound

(C-H)

cm-1 Aromatic

(C-H)

cm-1 Aliphatic

(C=C)

cm-1 Aromatic

(C=N)

cm-1 Imidazole

(C-S)

cm-1

(N-H)

cm-1

(O-H)

cm-1 Aromatic

(O-H)

cm-1 Aliphatic

2-MBI

3040

-

1515

1624

659

3159

-

-

AK1

3056

2916

1567

1616

675

3345

3434

-

AK2

3078

2878

1582

1618

665

3450

3391

-

AK3

3075

2943

1534

1626

683

3345

3472

-

AK4

3067

2924

1547

1610

645

3328

-

3250

AK5

3086

2897

1576

1613

634

3245

-

3267

AK6

3048

2904

1539

1623

662

3187

-

3278

AK7

3021

2934

1579

1630

651

3376

-

-

AK8

3062

2940

1545

1628

674

3469

-

-

AK9

3059

2884

1549

1620

639

3328

-

-

AK10

3027

2893

1529

1616

645

3378

-

3254

AK11

3075

2939

1519

1623

672

3421

-

3269

AK12

3091

2928

1567

1627

682

3146

-

3288

 

Table 5. 1HNMR spectral data of synthesized derivatives

Compound

δ (ppm) ¹H-NMR (DMSO-d, 400 MHz)

AK1

6.43-7.59 (m, 13H, Ar-H); 5.35 (s, 1H, OH); 4.94 (s, 1H, –NH); 4.70 (s, 2H, CH)

AK2

6.43-7.77 (m, 17H, Ar-H); 5.55 (s, 1H, OH); 5.14 (s, 1H, –NH); 4.94 (s, 1H, CH)

AK3

6.23-7.44 (m, 18H, Ar-H); 5.25 (s, 1H, OH); 5.22 (s, 1H, –NH); 4.88 (s, 1H, CH)

AK4

7.22-7.89 (m, 9H, Ar-H); 3.65 (s, 2H, OH); 5.04 (s, 1H, –NH); 4.95 (s, 1H, CH), 2.55 (s, 2H, CH), 3.65 (s, 2H, CH)

AK5

7.13-7.59 (m, 4H, Ar-H); 3.35 (s, 2H, OH); 4.94 (s, 1H, –NH); 3.95 (s, 2H, CH2), 2.53 (s, 2H, CH), 3.45 (s, 2H, CH)

AK6

7.17-7.69 (m, 9H, Ar-H); 3.55 (s, 2H, OH); 4.94 (s, 1H, –NH); 4.85 (s, 1H, CH), 2.55 (s, 2H, CH), 3.63 (s, 2H, CH)

 

SUPPLEMTARY FIGURES

Figure S1 FTIR spectra of AK1

 

Figure S2 FTIR spectra of AK2

 

Figure S3 FTIR spectra of AK3

 

Figure S4 FTIR spectra of AK4

 

Figure S5 FTIR spectra of AK5

 

Figure S6 FTIR spectra of AK6

 

Figure S7 FTIR spectra of AK7

 

Figure S8 FTIR spectra of AK8

 

Figure S9 FTIR spectra of AK9

 

Figure S10 FTIR spectra of AK10

 

Figure S11 FTIR spectra of AK11

 

Figure S12 FTIR spectra of AK12

DISCUSSION:

This study is concerned with the synthesis of structurally diverse Mannich base derivatives of a privileged heterocyclic scaffold. 2-Mercaptobenzimidazole, that is well-documented for its broad spectrum of biological activities . The Mannich reaction was selected as a strategic synthetic tool owing to its operational simplicity, functional group tolerance, and capability of introducing amino-methyl substituents that can considerably modulate physicochemical and biological properties. Twelve Mannich bases were prepared by reflux condensation of 2-Mercaptobenzimidazole with secondary amines in the presence of different linkers in mild acidic conditions (Gupta et al., 2015). The reaction takes place in two steps. TLC was employed to check the reaction progress after completion compounds were purified and recrystallized from ethanol/n-hexane. Spectroscopic analyses confirmed the successful formation of Mannich bases. The FTIR spectra of all synthesized compounds had characteristic shifts, representing newly formed C-N bonds, disappearance of thiol-associated vibrations, and the presence of secondary amine (N-H) and hydroxyl (O-H) stretching bands, confirming amino-methylation at the nucleophilic center of 2-Mercaptobenzimidazole. The 1HNMR spectra further corroborated these structure assignments due to the presence of diagnostic singlets corresponding to methylene (-CH-) protons bridging the benzimidazole nucleus and the amine moieties. Benzimidazole and 2-Mercaptobenzimidazole have gained considerable interest in the field of medicinal chemistry, as these both have ring structures that have biological activity (Wazir et al., 2025, Jakopin and Dolenc, 2010).

 

However, the nature of variation in the linker and secondary amine used could be responsible for the yield and physical characteristics differences among the synthesized compounds. Generally, formaldehyde-based Mannich reactions gave good yields probably because of increased electrophilicity and reduced steric hindrance, while aromatic aldehydes bulkier in nature and drug-based amines gave comparatively moderate yields. Worth noting are the incorporation of pharmacologically active secondary amines such as tizanidine, cefotaxime, and ceftazidime, which significantly raised the molecular weight and structural complexity that may influence the biological interaction.

 

Although the main focus of the present chemistry-oriented study was not comprehensive biological evaluation, preliminary screening indeed showed that aromatic or drug-linked amine moieties bearing compounds AK7–AK12 exhibited comparatively better biological responses. The presence of electron-withdrawing substituents like the 4-chloro group appeared to favor activity by increasing lipophilicity or by improving receptor binding interactions. This observation forms an initial structure activity relationship framework; both electronic effects as well as steric factors appear to play a modulating role in biological performance.

CONCLUSION:

A total of twelve new Mannich base compounds derived from 2-Mercapto-benzimidazole (AK1-AK12) were synthesized via a simple and effective method. The results confirmed by FTIR and 1HNMR proved that these compounds were synthesized correctly and were obtained with good to excellent yields under mild reaction conditions. Some initial screening results indicate that modifying these compounds with amino-methylation reactions involving aromatic and drug-related compounds may lead to compounds with increased biological properties. The significance of this paper is presented due to its potential applications and contribution to research and development regarding medicinal chemistry optimization studies involving 2-mercapto-benzimidazole-derived Mannich bases.

REFERENCES:

1.                Abbasi, I., Nadeem, H., Saeed, A., Kharl, H. A. A., Tahir, M. N., & Naseer, M. M. (2021). Isatin-hydrazide conjugates as potent α-amylase and α-glucosidase inhibitors: Synthesis, structure and in vitro evaluations. Bioorganic Chemistry, 116, 105385.

2.                Ahamed MR, Narren S F and Sadiq A S (2013). Synthesis of 2- mercaptobenzimidazole and some of its derivatives. ANJS, 16(2): 77-83.

3.                Ali Kharl, H.A., Nadeem, H., Khan, A.U., Mehreen, A., Afzal, A., Mehdi, S.M.Q., Adamova, U., Fozilova, S (2025). Synthesis, Molecular Docking, and Investigation of Enzyme Inhibition Activities of Benzimidazole-Pyrazole Hybrids. J. Vis. Exp. (1), e67661.

4.                Anandarajagopal K, Tiwari RN, Venkateshan N, PooshanG and Promwichit P (2010). Synthesis and characterization of 2-mercaptobenzimidazole derivatives as potential analgesic agents. J Chem Pharm Res, 2(1) 230-236.

5.                Bakhareva E, Voronkov M, Sorokin M, Lopyrev V, Seredenin S and Gaidarov G (1996). Synthesis and neurotropic properties of 2-(carboxymethylthio) derivatives of benzimidazole, benzothiazole and their ammonium salts. Pharm Chem J, 30(3) 89-91.

6.                Desai KG and Desai KR (2006). Green route for the heterocyclization of 2 mercaptobenzimidazole into β-lactum segment derivatives containingconhbridge with benzimidazole: screening in vitro antimicrobial activity with various microorganisms. J Chem Educ, 14(2) 8271-8279.

7.                Fahmy H, Aboutabl M and Abdel Azzem M (1986). On the electrochemical behaviour of some 2, 3dihydrothiazolo [3, 2a] benzimidazol3one and 1ethylmercapto34h)isoquinolones derivatives. J Chin Chem Soc-Taip, 33(5) 123- 132.

8.                Galloway WR, Isidro-Llobet A and Spring DR (2010). Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nature Commun, 1(6) 80.

9.                Gupta S, Gupta SP, Upmanyu N and Garg G (2015). Synthesis and biological evaluation of 2-mercaptobenzimidazole derivatives as anti-inflammatory agents. J Drug Design Med Chem, 1(4) 12-16.

10.             Husain A, Varshney M, Rashid M, Mishr R and Akhter A (2011). Benzimidazole: a valuable insight into the recent advances and biological activities. J. Pharm. Res, 4(1) 413-419.

11.             Jakopin Z and Dolenc MS (2010). Advances in the chemistry of saccharins: from synthetic novelties towards biologically active compounds. Curr Med Chem, 17(3) 651-671.

12.             Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA and Banerje SN (20010. Transfusiontransmitted bacterial infectionin the united states, 1998 through 2000. Transfusion, 41(4) 1493-1499.

13.             Luo HT, Kang YR., Nie HY and Yang LM (2009). Sulfamic acid as a costeffective and recyclable catalyst for β‐amino carbonyl compounds synthesis. J Chin Chem Soc, 56(7):186-195.

14.             Mannich C and Krösche W (1912). Ueber ein kondensationsprodukt aus formaldehyde, ammoniak und antipyrin. Archiv der pharmazie, 250(13) 647-667.

15.             Mauro V, Silvia H, Joao V and Marcus V (2007). Synthesis of 2-mercapto benzthiazole and 2-mercaptobenzimidazole derivatives condensed with carbohydrates as a potential antimicrobial agents. J Sulfur Chem, 28(4) 17.

16.             Mor M, Bordi F, Silva C, Rivara S, Zuliani V, Vacondio F, Rivara M, Barocelli E, Bertoni S and Ballabeni V (2004). Synthesis, biological activity, qsar and qspr study of 2 aminobenzimidazole derivatives as potent h3-antagonists. Bioorg Med Chem, 12(2): 663-674.

17.             Norford DC, Meuten DJ, Cullen JM and Collins JJ (1993). Pituitary and thyroid gland lesions induced by 2-mercaptobenzimidazole (2-mbi) inhalation in male fischer-344 rats. Toxicologic pathology, 21(4) 456-464.

18.             Rebstock TL, Ball CD, Hamner CL and Sell HM (1955). Inhibition of plant growth by 2 mercaptobenzimidazole analogs. Plant physiology, 30(4) 382.

19.             Reddy SR, Kalyani P, Rao BR and Manikyamba P (2008). Computational studies and reactivity of nucleophiles in benzylation reactions. J Comp Med Chem, 12(3) 123.

20.             Ried W and Stahlhofen P (1957). Über heterocyclische siebenringsysteme, v. Umsetzung von ophenylendiamin mit α, β‐ungesättigten carbonylverbindungen. Chemische berichte, 90(11) 815-824.

21.             Saxena D, Khajuria R and Suri O (1982). Synthesis and spectral studies of 2mercaptobenzimidazole derivatives. Int J Heterocyclic Chem, 19(2) 681-683.

22.             Tramontini M (1973). Advances in the chemistry of Mannich bases. Synthesis, 1973, 703775.

23.             Tramontini M and Angiolini L (1990). Further advances in the chemistry of mannich bases. Tetrahedron, 46(15) 1791-1837.

24.             Tramontini M and Angiolini L (1994). Mannich bases-chemistry and uses, 5th ed. Zees and Fee; p.124.

25.             Wazir, S., Abid, F., Mobashar, A., Shabbir, A., Awais, M., Nadeem, H., & Alanzi, A. R. (2025). Anti-arthritic and anti-inflammatory effects of BMZD-2CPE in a CFA and carrageenan-induced animal model. Naunyn-Schmiedeberg's Archives of Pharmacology, 1-14.

26.             Welsch ME, Snyder SA and Stockwell BR (2010). Privileged scaffolds for library design and drug discovery. Curr Opinion Chem Biol, 14(4) 347-361.

27.             Yang Y, Phillips DP and Pan S (2011). A stereoselective approach to 6-alkylated piperidinone & 2-piperidine via three-component vinylogous mannich reactions (vmr) and a concise synthesis of (s)-anabasine. Tetrahedron lett, 52(11) 1549-1552.